β Home
βΉοΈ Info
π§Ύ Overview π Core Facts π₯ Video Insights β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π’ Company Q&A π οΈ Industry Q&A π Competitors π Stock Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risks π§© Segmentationπ§ Tools
β Due DiligenceCash Flow Statement
Pay attention and research significant changes from year to year values. [ ! ]
Fixed Column | Net Income | Depreciation And Amortization | Deferred Income Tax | Stock Based Compensation | Change In Working Capital | Accounts Receivables | Inventory | Accounts Payables | Other Working Capital | Other Non Cash Items | Net Cash Provided By Operating Activities | Investments In Property Plant And Equipment | Acquisitions Net | Purchases Of Investments | Sales Maturities Of Investments | Other Investing Activities | Net Cash Used For Investing Activities | Debt Repayment | Common Stock Issued | Common Stock Repurchased | Dividends Paid | Other Financing Activities | Net Cash Used Provided By Financing Activities | Effect Of Forex Changes On Cash | Net Change In Cash | Cash At End Of Period | Cash At Beginning Of Period | Operating Cash Flow | Capital Expenditure |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-12 | 492.7 | 155.4 | 0.0 | 18.7 | 2.9 | 0.0 | 0.0 | 2.9 | 0.0 | -16.3 | 653.4 | -377.0 | 0.0 | 0.0 | 0.0 | -1.7 | -378.7 | -27.6 | 0.0 | -566.6 | -59.1 | 30.7 | -622.6 | -21.4 | -369.3 | 484.6 | 853.9 | 653.4 | -377.0 |
2023-12 | 593.4 | 137.3 | 37.5 | 23.3 | -20.39 | 4.0 | -13.5 | 4.4 | -15.3 | 5.4 | 776.5 | -362.0 | 0.0 | 0.0 | 0.0 | -6.7 | -368.7 | -2.29 | 0.0 | -451.2 | -57.0 | 50.9 | -459.6 | 11.4 | -40.4 | 853.9 | 894.3 | 776.5 | -362.0 |
2022-12 | 585.9 | 120.6 | -30.8 | 23.7 | -11.5 | -35.6 | -49.8 | -2.8 | 76.7 | 36.1 | 724.0 | -284.6 | 0.0 | 0.0 | 0.0 | -3.6 | -288.2 | -44.3 | 0.0 | -222.2 | -54.1 | 27.0 | -293.6 | -10.5 | 131.69 | 894.3 | 762.6 | 724.0 | -284.6 |
2021-12 | 661.8 | 122.3 | -42.9 | 37.5 | -193.8 | -123.5 | -86.5 | 16.8 | -0.6 | -0.9 | 584.0 | -253.4 | -2.2 | 0.0 | 0.0 | 2.5 | -253.1 | -2.2 | 0.0 | -151.9 | -51.1 | 37.1 | -168.1 | -15.7 | 147.1 | 762.6 | 615.5 | 584.0 | -253.4 |
2020-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2019-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2018-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2017-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2016-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2015-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2014-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |

π Explore more cash flow data for West Pharmaceutical Services!
Sign up for free or log inπ Donβt miss "The Checklist Value Investor β A Smarter Way to Pick Stocks" β free!